PCSK9 Inhibitors: A New Era in Lipid-Lowering Treatment?

被引：13
|
作者：
Cainzos-Achirica, Miguel [1 ]
Martin, Seth S. [1 ]
Cornell, John E.
Murow, Cynthia D.
Guallar, Eliseo
机构：
[1] Johns Hopkins Med Inst, Baltimore, MD 21205 USA
来源：
ANNALS OF INTERNAL MEDICINE | 2015年 / 163卷 / 01期
关键词：
HYPERCHOLESTEROLEMIA; LDL;
D O I：
10.7326/M15-0920
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：64 / 65
页数：2
相关论文
共 50 条
  • [1] PCSK9 inhibitors: an overview on a new promising lipid-lowering therapy
    Denegri, Andrea
    Petrova-Slater, Iveta
    Pasotti, Elena
    Rossi, Maria Grazia
    Pedrazzini, Giovanni Battista
    Moccetti, Tiziano
    Moccetti, Marco
    JOURNAL OF CARDIOVASCULAR MEDICINE, 2016, 17 (04) : 237 - 244
  • [2] Recent advances in developing PCSK9 inhibitors for lipid-lowering therapy
    Lavecchia, Antonio
    Cerchia, Carmen
    FUTURE MEDICINAL CHEMISTRY, 2019, 11 (05) : 423 - 441
  • [3] PCSK9: a new target for lipid lowering treatment
    Costet, Philippe
    Cariou, Bertrand
    Krempf, Michel
    SANG THROMBOSE VAISSEAUX, 2007, 19 (03): : 137 - 142
  • [4] Rapid effects of different lipid-lowering drugs on PCSK9 in humans
    Liu, Jun
    Guo, Yuan-Lin
    Xu, Rui-Xia
    Li, Jian-Jun
    CLINICAL LIPIDOLOGY, 2013, 8 (05) : 519 - 524
  • [5] PCSK9 inhibitors for LDL lowering
    Walsh, Lames P.
    TRENDS IN CARDIOVASCULAR MEDICINE, 2015, 25 (07) : 575 - 577
  • [6] Lower is better: ezetimibe and PCSK9 inhibition join the mainstream of lipid-lowering therapy
    Wojcik, Cezary
    REVIEWS IN HEALTH CARE, 2016, 7 (01) : 17 - 25
  • [7] Effect of adding PCSK9 inhibitors to lipid-lowering interventions on arterial stiffness: A systematic review and meta-analysis
    Cavero-Redondo, I.
    Moreno-Herraiz, N.
    Del Saz-Lara, A.
    Otero-Luis, I.
    Recio-Rodriguez, J. I.
    Saz-Lara, A.
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2024, 54 (10)
  • [8] PCSK9 inhibitors
    Farnier, Michel
    CORRESPONDANCES EN METABOLISMES HORMONES DIABETES ET NUTRITION, 2015, 19 (03): : 66 - 70
  • [9] PCSK9 inhibitors- A new age in lipid management?
    Grant, Peter J.
    DIABETES & VASCULAR DISEASE RESEARCH, 2017, 14 (03): : 171 - 171
  • [10] Impact of currently prescribed lipid-lowering drugs on plasma PCSK9 concentration: single or in combination study in rats
    Zhang, Yan
    Liu, Jun
    Li, Sha
    Xu, Rui-Xia
    Sun, Jing
    Li, Jian-Jun
    LIPIDS IN HEALTH AND DISEASE, 2014, 13
12345